Literature DB >> 12868470

Spondyloenchondromatosis with D-2-hydroxyglutaric aciduria: a report of a second patient with this unusual combination.

E M Honey1, M van Rensburg, D P Knoll, L J Mienie, I van de Werke, P Beighton.   

Abstract

Spondyloenchondromatosis (SEM) is a rare skeletal dysplasia which presents with multiple enchondromata in the metaphyses of the long bones associated with dysplastic vertebral bodies. It is probably heterogeneous. We have investigated and documented a male infant in South Africa with spondyloenchondromatosis and persistent D-2-hydroxyglutaric aciduria (D2HA). D2HA is a neurometabolic disorder whose enzymatic basis is still undefined. A girl in England with a similar clinical, radiological and biochemical phenotype has previously been reported by Talkhani et al. [(2000). Skel Radiol 7:215-2921]. There is at present a lack of a plausible pathogenetic relationship between the two components of the disorder but a contiguous gene syndrome or a pleiotropic gene could be considered. Whatever the underlying mechanism this case report confirms its nosological entity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12868470     DOI: 10.1097/00019605-200304000-00004

Source DB:  PubMed          Journal:  Clin Dysmorphol        ISSN: 0962-8827            Impact factor:   0.816


  10 in total

Review 1.  Inborn errors of metabolism for the diagnostic radiologist.

Authors:  Chris J Hendriksz
Journal:  Pediatr Radiol       Date:  2008-12-13

2.  Metaphyseal chondromatosis combined with D-2-hydroxyglutaric aciduria in four patients.

Authors:  Hye Jung Choo; Tae-Joon Cho; Junghan Song; George E Tiller; Sun Hee Lee; Gunbo Park; In Sook Lee; Ralph Lachman; Andrea Superti-Furga; Ok-Hwa Kim
Journal:  Skeletal Radiol       Date:  2012-05-26       Impact factor: 2.199

Review 3.  D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect.

Authors:  Eduard A Struys
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

Review 4.  Enchondromatosis: insights on the different subtypes.

Authors:  Twinkal C Pansuriya; Herman M Kroon; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2010-06-26

5.  Peripheral neuropathy in a patient with D-2-hydroxyglutaric aciduria.

Authors:  G Haliloglu; C M Temucin; K K Oguz; A Celiker; T Coskun; J O Sass; J Fischer; M Topcu
Journal:  J Inherit Metab Dis       Date:  2009-01-26       Impact factor: 4.982

6.  Widespread and debilitating hemangiomas in a patient with enchondromatosis and D-2-hydroxyglutaric aciduria.

Authors:  Patra Yeetong; Teerasak Phewplung; Wuttichart Kamolvisit; Kanya Suphapeetiporn; Vorasuk Shotelersuk
Journal:  Skeletal Radiol       Date:  2018-05-10       Impact factor: 2.199

Review 7.  Progress in understanding 2-hydroxyglutaric acidurias.

Authors:  Martijn Kranendijk; Eduard A Struys; Gajja S Salomons; Marjo S Van der Knaap; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

8.  Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.

Authors:  D Thirumal Kumar; L Jerushah Emerald; C George Priya Doss; P Sneha; R Siva; W Charles Emmanuel Jebaraj; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-09       Impact factor: 3.655

9.  The oncometabolite D-2-hydroxyglutarate induced by mutant IDH1 or -2 blocks osteoblast differentiation in vitro and in vivo.

Authors:  Johnny Suijker; Hans J Baelde; Helene Roelofs; Anne-Marie Cleton-Jansen; Judith V M G Bovée
Journal:  Oncotarget       Date:  2015-06-20

10.  D-2-Hydroxyglutaric Aciduria with Enchondromatosis and Angiokeratoma Circumscriptum.

Authors:  Allie Preston; Kara Reardon; Neil Crowson; Walter Lamar; Jason M Hirshburg
Journal:  Cureus       Date:  2019-11-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.